J&J’s vaccine set to move to human trials as it works in primates
The US drugmaker says the vaccine prevented infection and protected the animals’ lungs from the coronavirus
30 July 2020 - 12:36
New York/Paris — Johnson & Johnson’s experimental coronavirus vaccine protected a handful of primates with a single shot in an early study, prompting the US drugmaker to start trials on humans this month.
The vaccine prevented infection and protected the animals’ lungs from the virus, J&J said in a statement on Thursday. The healthcare behemoth kick-started human trials on July 22 in Belgium, and in the US earlier this week...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.